{"doi": "10.64898/2026.08.24.26361220", "chapters": [{"t": 0.0, "label": "Cold open"}, {"t": 43.41, "label": "Why this exists"}, {"t": 104.34, "label": "What they actually did"}, {"t": 203.25, "label": "What they found"}, {"t": 327.37, "label": "Caveats"}, {"t": 406.91, "label": "Who should care"}, {"t": 490.24, "label": "Outro"}], "turns": [{"beat": 1, "speaker": "A", "t": 0.0, "dur": 17.92, "text": "Rest tremor in Parkinson disease has a weird relationship with dopamine. The more dopamine loss you see on one side of the brain, the more tremor shows up on that same side — which sounds like it should make sense, but it probably doesn't. That's what this paper challenges."}, {"beat": 1, "speaker": "B", "t": 18.2, "dur": 10.11, "text": "Wait, that sounds backwards. Parkinson tremor is supposed to come from the opposite side of the brain, right? The left hemisphere controls the right side of the body."}, {"beat": 1, "speaker": "A", "t": 28.59, "dur": 13.89, "text": "Exactly. That's the catch. The authors are saying this ipsilateral correlation — same-side binding and tremor — might not reflect how tremor actually works. It might just be a statistical mirage."}, {"beat": 2, "speaker": "B", "t": 43.41, "dur": 2.69, "text": "So why are we confused about this in the first place?"}, {"beat": 2, "speaker": "A", "t": 46.38, "dur": 14.81, "text": "Because the ipsilateral tremor-dopamine correlation keeps showing up. Multiple groups have found it, with different imaging tracers, in different cohorts. It's reproducible. But reproducible doesn't mean you understand what it means."}, {"beat": 2, "speaker": "B", "t": 61.46, "dur": 1.73, "text": "What are the two competing ideas?"}, {"beat": 2, "speaker": "A", "t": 63.47, "dur": 24.45, "text": "One is that there's a real, direct circuit: less dopamine on the left side directly causes more tremor on the left side — a dose-dependent relationship. The other is simpler: patients who get tremor just happen to have a different overall pattern of dopamine loss across the whole striatum, and that difference alone creates the correlation without any tremor-specific mechanism."}, {"beat": 2, "speaker": "B", "t": 88.2, "dur": 7.04, "text": "So it's not about the tremor circuit at all — it's just a marker that tremor-prone patients have different dopamine loss overall?"}, {"beat": 2, "speaker": "A", "t": 95.52, "dur": 7.89, "text": "That's the hypothesis they're testing. And the key insight is: these two ideas make different predictions about severity."}, {"beat": 3, "speaker": "B", "t": 104.34, "dur": 1.45, "text": "How do you tell them apart?"}, {"beat": 3, "speaker": "A", "t": 106.07, "dur": 15.23, "text": "If dopamine loss directly causes tremor amplitude, then more dopamine loss should predict more tremor. If it's just a group-level difference, dopamine loss should predict whether someone has tremor at all, but not how bad it is."}, {"beat": 3, "speaker": "B", "t": 121.59, "dur": 1.96, "text": "Clever. So what data did they use?"}, {"beat": 3, "speaker": "A", "t": 123.83, "dur": 29.06, "text": "Two cohorts from the Parkinson's Progression Markers Initiative, or PPMI. The baseline cohort had 1,055 patients, average age 63 and a half years. The follow-up cohort had 652 patients, measured about 2.2 years after enrollment. Each patient had a dopamine transporter PET scan — that's DAT-SPECT — and a motor exam called the MDS-UPDRS-III done within 91 days."}, {"beat": 3, "speaker": "B", "t": 153.16, "dur": 3.78, "text": "And they measured rest tremor, bradykinesia, and rigidity separately?"}, {"beat": 3, "speaker": "A", "t": 157.22, "dur": 22.7, "text": "Right. They pulled out left and right severity scores for each symptom from the exam. Then they did something clever: a permutation test. They held patients without tremor fixed, then randomly shuffled the severity scores among tremor-positive patients 10,000 times, and asked whether the original correlation was any different from that shuffled null."}, {"beat": 3, "speaker": "B", "t": 180.2, "dur": 4.95, "text": "That's a clever way to isolate severity-dependent effects from just group differences."}, {"beat": 3, "speaker": "A", "t": 185.43, "dur": 16.9, "text": "Exactly. They also did out-of-sample prediction — leave-one-out cross-validation — to see whether dopamine binding predicted tremor presence versus severity. They looked at both the caudate and putamen, both ipsilateral and contralateral."}, {"beat": 4, "speaker": "B", "t": 203.25, "dur": 1.34, "text": "Okay, so what happened?"}, {"beat": 4, "speaker": "A", "t": 204.88, "dur": 26.01, "text": "Bradykinesia and rigidity behaved as expected. They showed large contralateral correlations with striatal dopamine binding — in the baseline cohort, correlation coefficients between minus 0.20 and minus 0.38, all highly significant. And those correlations survived the permutation test, meaning they're real severity-dependent effects."}, {"beat": 4, "speaker": "B", "t": 231.16, "dur": 2.54, "text": "The opposite side of the brain, as it should be."}, {"beat": 4, "speaker": "A", "t": 233.98, "dur": 19.95, "text": "Right. Rest tremor was different. It showed modest positive ipsilateral correlations — plus 0.11 to plus 0.22 — but those correlations were not distinguishable from the permutation null. In other words, when you shuffle severity around, the correlation doesn't go away."}, {"beat": 4, "speaker": "B", "t": 254.21, "dur": 3.73, "text": "So the correlation was there, but it wasn't a real severity effect."}, {"beat": 4, "speaker": "A", "t": 258.22, "dur": 23.34, "text": "Exactly. Then they tested prediction. Rest tremor presence was predicted from dopamine binding on either side — ipsilateral or contralateral — with an AUC of 0.55 to 0.61. But severity among tremor-positive patients? R-squared of 0.002 or less. Essentially zero."}, {"beat": 4, "speaker": "B", "t": 281.84, "dur": 2.24, "text": "Whereas bradykinesia did the opposite?"}, {"beat": 4, "speaker": "A", "t": 284.36, "dur": 24.87, "text": "Yes. Contralateral putamen binding predicted both presence and severity of bradykinesia — AUC 0.65 to 0.74 for presence, R-squared 0.015 to 0.056 for severity. That's the pattern you'd expect from a direct, dose-dependent mechanism. The same pattern held in the follow-up cohort."}, {"beat": 4, "speaker": "B", "t": 309.52, "dur": 5.4, "text": "So the methods work — they can detect real dose-dependent effects — but tremor doesn't show them."}, {"beat": 4, "speaker": "A", "t": 315.19, "dur": 11.24, "text": "Correct. The quieter finding is that tremor presence was predicted equally well from ipsilateral and contralateral binding, which is weird if the mechanism is ipsilateral."}, {"beat": 5, "speaker": "B", "t": 327.37, "dur": 1.34, "text": "What are the limitations?"}, {"beat": 5, "speaker": "A", "t": 328.99, "dur": 22.49, "text": "The authors flag a few. Symptom severity came from ordinal MDS-UPDRS-III items, which coarsen the data. If there's a real but very small dose-response relationship, ordinal scores might miss it. But the same coarse measure detected the expected relationship for bradykinesia and rigidity, so that's not a complete escape."}, {"beat": 5, "speaker": "B", "t": 351.75, "dur": 0.85, "text": "What else?"}, {"beat": 5, "speaker": "A", "t": 352.89, "dur": 19.39, "text": "Bradykinesia is measured from five items with a wider dynamic range than tremor, which is measured from fewer items. That asymmetry could matter. The authors themselves say the presence analysis for bradykinesia should be interpreted cautiously — the severity analysis is more informative."}, {"beat": 5, "speaker": "B", "t": 372.56, "dur": 1.41, "text": "And beyond what they flag?"}, {"beat": 5, "speaker": "A", "t": 374.25, "dur": 20.84, "text": "The sample is from a single multi-site cohort — PPMI. Replication in independent cohorts would strengthen the findings. Also, this is a preprint, so it hasn't been peer-reviewed yet. And the permutation test, while clever, is more statistically demanding than conventional testing, so it might be conservative."}, {"beat": 5, "speaker": "B", "t": 395.37, "dur": 8.02, "text": "Fair. But the fact that their methods caught the expected effect for bradykinesia and rigidity suggests they're not just too conservative."}, {"beat": 5, "speaker": "A", "t": 403.67, "dur": 2.3, "text": "Right. That's a good internal control."}, {"beat": 6, "speaker": "A", "t": 406.91, "dur": 19.75, "text": "Three groups should care. First, movement disorder neurologists and Parkinson researchers. This changes how to interpret the ipsilateral tremor-dopamine correlation they've been seeing. It's not a circuit mechanism, so don't build models around ipsilateral dopaminergic control of tremor."}, {"beat": 6, "speaker": "B", "t": 426.94, "dur": 1.79, "text": "What's the practical implication?"}, {"beat": 6, "speaker": "A", "t": 429.01, "dur": 11.82, "text": "If you're developing therapies targeting dopamine for tremor, this suggests you should think about what makes tremor-prone patients different globally, not about local ipsilateral circuits."}, {"beat": 6, "speaker": "A", "t": 441.11, "dur": 23.02, "text": "Second, people working on Parkinson subtypes. Tremor-dominant PD follows a distinct clinical course from akinetic-rigid PD. This paper suggests there's a real, distinct dopaminergic phenotype in tremor-dominant disease — not just a difference in symptom presentation, but a difference in the underlying pattern of dopamine loss."}, {"beat": 6, "speaker": "B", "t": 464.41, "dur": 2.75, "text": "That matters for prognosis and stratification."}, {"beat": 6, "speaker": "A", "t": 467.44, "dur": 21.87, "text": "Exactly. Third, computational modelers and biostatisticians. This is a nice example of how a robust, reproducible correlation can be misinterpreted without the right statistical test. The permutation approach and the distinction between predicting presence versus severity are both generalizable ideas."}, {"beat": 7, "speaker": "A", "t": 490.24, "dur": 27.2, "text": "The full citation: Mendonça, Marcelo D, and Joaquim Alves da Silva. Ipsilateral rest tremor-dopamine transporter correlation reflects a broader dopaminergic difference, not tremor-specific pathophysiology. medRxiv, 2026. DOI: 10.64898, slash, 2026.08.24.26361220."}, {"beat": 7, "speaker": "B", "t": 517.72, "dur": 1.83, "text": "The thread is open on Colloquy."}]}